Blueprint Medicines Corp
Change company Symbol lookup
Select an option...
BPMC Blueprint Medicines Corp
OSCR Oscar Health Inc
LGVN Longeveron Inc
WW WW International Inc
GACQ Global Consumer Acquisition Corp
ERNA Eterna Therapeutics Inc
PRIF-G Priority Income Fund Inc
EFXT Enerflex Ltd
BIPC Brookfield Infrastructure Corp
TWCB Bilander Acquisition Corp
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Blueprint Medicines Corporation is a global precision therapy company that is inventing medicines for people with cancer and blood disorders. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib) to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer and other genomically defined cancers, and cancer immunotherapy. Its pipelines also include BLU-263 (KIT), AYVAKIT (avapritinib) (PDGFRA), BLU-701 (EGFR), BLU-945 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing and commercializing avapritinib for the treatment of advanced SM, and developing avapritinib for the treatment of non-advanced SM. The Company is developing BLU-263, an investigational, orally available KIT inhibitor, for the treatment of non-advanced SM and other mast cell disorders.

Closing Price
$46.85
Day's Change
-1.66 (-3.42%)
Bid
--
Ask
--
B/A Size
--
Day's High
48.58
Day's Low
46.68
Volume
(Light)
Volume:
371,965

10-day average volume:
593,519
371,965
  • Prev Close
    48.51
  • Today's Open
    48.11
  • Day's Range
    46.68-48.58
  • Avg Vol (10-day)
    593.5K
  • Last (time)
    3:59p ET 12/07/22
  • Last (size)
    25
  • 52-Wk Range
    40.78 - 111.78
    LowHigh
  • (12/23/21 - 11/09/22)
    14.88%
  • 63.3%
  • Market Cap
    2.8B
  • Shares Outstanding
    59.8M
  • -12.10
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.6
  • 104.85
  • (% of float 11/15/22)
    7.15

Latest News

December 05, 2022
5:01 pm ET
PR Newswire
November 22, 2022
4:36 pm ET
PR Newswire
November 09, 2022
4:01 pm ET
PR Newswire
November 04, 2022
4:01 pm ET
PR Newswire
November 03, 2022
9:01 am ET
PR Newswire
November 02, 2022
7:43 am ET
MarketWatch
7:41 am ET
MarketWatch
October 19, 2022
8:00 am ET
PR Newswire
October 06, 2022
4:30 pm ET
PR Newswire
September 21, 2022
5:30 pm ET
Accesswire
August 17, 2022
9:01 am ET
MarketWatch
July 08, 2022
7:37 am ET
MarketWatch
June 30, 2022
8:42 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.